StonvexLoading…
StonvexStonvexStonvexCore line items from NXDT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $22.88M | $85.97M | $67.57M | $50.11M |
Operating Income | $3.45M | $-1.38M | $2.07M | $5.40M |
Net Income | $-22.97M | $-130.19M | $-93.26M | $-79.57M |
EPS (Diluted) | $-0.46 | $-2.81 | $-2.06 | $-1.80 |
Total Assets | $1.03B | $1.07B | $1.11B | $1.11B |
Total Liabilities | $323.63M | $353.87M | $356.54M | $354.77M |
Cash & Equivalents | $9.43M | $8.17M | $5.31M | $4.73M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 51.65M | 50.13M | 49.02M | 47.42M |